Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells

Abstract

Mounting evidence supports that a newly identified regulatory T cell (Treg), CD4⁺LAP⁺ Treg, is associated with oral tolerance induction and following inhibition of atherosclerosis, but little is described about whether nasal tolerance to antigen likewise induces the novel Tregs production and the relevant antiatherosclerotic benefit. We investigated the effect of nasal administration of heat shock protein-60 (HSP60) on atherogenesis. HSP60 or phosphate buffer solution (PBS) was nasally administered to six-week-old male ApoE^−/− mice. At the 10th week after the nasal administration, there was a significant decrease in atherosclerotic plaque areas of aortic roots in the HSP60-treated mice as compared with those in the PBS-treated mice. Atherosclerosis suppression was accompanied with a significant increase in CD4⁺LAP⁺ and CD4⁺CD25⁺Foxp3⁺ Tregs and a concurrently increased production of TGF-β in the HSP60-treated mice. The protective effect of HSP60 was offset by injection of anti-TGF-β antibody. It is concluded that nasal administration of HSP60 can inhibit atherosclerotic formation through immune tolerance which is established by Tregs depending on the induction of anti-inflammatory cytokine TGF-β. Immune tolerance induced by nasal administration of HSP60 may provide an alternative therapeutic method for atherosclerosis.

Keywords

atherosclerosis / inflammation / immune tolerance / heat shock protein / regulatory T cells

References

[1] RossR.. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340(2): 115-126

[2] HanssonG.K.. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352(16): 1685-1695

[3] ShererY., ShoenfeldY.. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol, 2006, 2(2): 99-106

[4] MontecuccoF., MachF.. Atherosclerosis is an inflammatory disease. Semin Immunopathol, 2009, 31(1): 1-3

[5] BenagianoM., D’EliosM.M., AmedeiA., et al.. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol, 2005, 174(10): 6509-6517

[6] BinderC.J., ChangM.K., ShawP.X., et al.. Innate and acquired immunity in atherogenesis. Nat Med, 2002, 8(11): 1218-1226

[7] HanssonG.K., HermanssonA.. The immune system in atherosclerosis. Nat Immunol, 2011, 12(3): 204-212

[8] XuQ., WickG.. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today, 1996, 2(9): 372-379

[9] JorgensenC., GedonE., JaquetC., et al.. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of typeII collagen induced arthritis in mice. J Rheumatol, 1998, 25(4): 763-767

[10] MaronR., SukhovaG., FariaA.M., et al.. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation, 2002, 106(13): 1708-1715

[11] HaratsD., YacovN., GiburdB., et al.. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol, 2002, 40(7): 1333-1338

[12] CobelensP.M., HeijnenC.J., NieuwenhuisE.E., et al.. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease. Arthritis Rheum, 2000, 43(12): 2694-2702

[13] MallatZ., Ait-OufellaH., TedguiA.. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol, 2005, 16(5): 518-524

[14] de KleerI.M., KamphuisS.M., RijkersG.T., et al.. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum, 2003, 48(7): 2001-2010

[15] PrakkenB.J., SamodalR., LeT.D., et al.. Epitope-specific immunotherapy induces immune deviation of proinflam matory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA, 2004, 101(12): 4228-4233

[16] van EdenW., van der ZeeR., PrakkenB.. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol, 2005, 5(4): 318-330

[17] FariaA.M., WeinerH.L.. Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol, 2006, 13(2–4): 143-157

[18] FariaA.M., WeinerH.L.. Oral tolerance. Immunol Rev, 2005, 206: 232-259

[19] Ait-OufellaH., SalomonB.L., PotteauxS., et al.. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med, 2006, 12(2): 178-180

[20] TalebS., TedguiA., MallatZ.. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med, 2008, 263(5): 489-499

[21] van PuijveldeG.H., van EsT., van WanrooijE.J., et al.. Induction of oral tolerance to HSP60 or an HSP60peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2677-2683

[22] LiuJ.Q., BaiX.F., ShiF.D., et al.. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68–86 and 87–99. Int Immunol, 1998, 10(8): 1139-1148

[23] ShiF.D., LiH., WangH., et al.. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. J Immunol, 1999, 162(10): 5757-5763

[24] XiongQ., LiJ., JinL., et al.. Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms. Immunol Lett, 2009, 125(1): 40-45

[25] VilskerstsR., LiepinshE., MateuszukL., et al.. Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR−/− mice. Pharmacology, 2009, 83(5): 287-293

[26] SakaguchiS., YamaguchiT., NomuraT., et al.. Regulatory T cells and immune tolerance. Cell, 2008, 133(5): 775-787

[27] SakaguchiS., SakaguchiN., AsanoM., et al.. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155(3): 1151-1164

[28] MallatZ., GojovaA., BrunV., et al.. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation, 2003, 108(10): 1232-1237

[29] van PuijveldeG.H., HauerA.D., de VosP., et al.. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation, 2006, 114(18): 1968-1976

[30] SasakiN., YamashitaT., TakedaM., et al.. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation, 2009, 120(20): 1996-2005

[31] SteffensS., BurgerF., PelliG., et al.. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation, 2006, 114(18): 1977-1984

[32] SamsomJ.N.. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit Rev Immunol, 2004, 24(3): 157-177

[33] OstroukhovaM., Seguin-DevauxC., OrissT.B., et al.. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest, 2004, 114(1): 28-38

[34] WanY.Y.. Regulatory T cells: immune suppression and beyond. Cell Mol Immunol, 2010, 7(3): 204-210

[35] NakamuraK., KitaniA., StroberW.. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med, 2001, 194(5): 629-644